Journal Article Summary
The article examines the use of low-dose aspirin for preventing cardiovascular disease (CVD) among African American adults in Minnesota from 2015 to 2019. This topic is significant because CVD disproportionately affects African Americans, leading to higher rates of morbidity and mortality compared to other racial groups. Recent changes in clinical guidelines and research findings have raised questions about the appropriateness of aspirin for primary prevention, making it crucial to understand how these factors influence aspirin use in this population.
The study involved three surveys conducted in the Minneapolis-Saint Paul area, gathering data from 1,491 African American adults aged 45 to 79 who had no history of CVD. Participants were asked about their health behaviors, beliefs regarding aspirin, and discussions with healthcare providers. The findings revealed that aspirin use remained stable over the three surveys, with no significant changes for either men or women. However, there was a decline in the belief that aspirin was beneficial for preventing CVD, dropping from 84% in 2015 to 75% in 2019.
Despite the study's insights, there are limitations to consider. The sample was drawn from convenience locations, which may not represent the broader African American community, and self-reported data could introduce bias. Additionally, the CVD risk assessment used was based on predominantly white populations, which may not accurately reflect the risk for African Americans. Readers are encouraged to discuss their aspirin use and CVD risk with healthcare professionals, especially in light of changing guidelines and individual health factors.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Van’t Hof Jeremy R., Duval Sue, Oldenburg Niki, Misialek Jeffrey R., Eder Milton, Jones Clarence, Finnegan John R., Luepker Russell V.. Low-Dose Aspirin for Primary Prevention of Cardiovascular Disease: Trends in Use Patterns among African American Adults in Minnesota, 2015–2019. Preventive medicine 2021. DOI: 10.1016/j.ypmed.2021.106589. PMID: 33930435. PMCID: PMC8169201.
Featured Pill Pals Product
OTC 1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
